NALTREXONE

UNII: 5S6W795CQM
Formula: C20H23NO4
Preferred Substance Name: NALTREXONE
InChIKey: DQCKKXVULJGBQN-XFWGSAIBSA-N

16590-41-3
240-649-9
17-(CYCLOPROPYLMETHYL)-4,5.ALPHA.-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE
EN-1639A FREE BASE
MORPHINAN-6-ONE, 17-(CYCLOPROPYLMETHYL)-4,5-EPOXY-3,14-DIHYDROXY-, (5.ALPHA.)-
NALTREXONE [HSDB]
NALTREXONE [INN]
NALTREXONE [MART.]
NALTREXONE [MI]
NALTREXONE [ORANGE BOOK]
NALTREXONE [USAN]
NALTREXONE [USP-RS]
NALTREXONE [VANDF]
NALTREXONE [WHO-DD]
NSC-758439
VIVITROL

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

NALTREXONE

Synonyms and Mappings

Resources

Note